Target Name: TMPRSS13
NCBI ID: G84000
Review Report on TMPRSS13 Target / Biomarker Content of Review Report on TMPRSS13 Target / Biomarker
TMPRSS13
Other Name(s): TMPRSS11 | Transmembrane protease serine 13 (isoform 1) | transmembrane serine protease 13 | Membrane-type mosaic serine protease | MSP | MSPL | transmembrane protease, serine 13 | Transmembrane protease, serine 13 | Transmembrane protease serine 13 | membrane-type mosaic serine protease | TMPRSS13 variant 1 | Transmembrane protease, serine 13, transcript variant 1 | TMPSD_HUMAN | Mosaic serine protease | transmembrane protease, serine 11 | MSPS

TMPRSS13: A Potential Drug Target and Biomarker for Multiple Diseases

TMPRSS13 (Transient receptor potential cation channel subfamily 13) is a protein that is expressed in many different tissues throughout the body. It is a potential drug target and has been identified as a biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

TMPRSS13 is a transmembrane protein that is characterized by its ability to regulate the flow of electrical currents through cells. It is a member of the transient receptor potential cation channel subfamily, which is a family of proteins that are involved in the regulation of ion channels in the cell membrane. These channels play a crucial role in the transmission of signals within the cell, and are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and muscle contractions.

Recent studies have identified TMPRSS13 as a potential drug target for several different diseases. For example, TMPRSS13 has been shown to be involved in the development and progression of cancer, and has been identified as a potential therapeutic target for this disease. Additionally, TMPRSS13 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target, TMPRSS13 has also been identified as a potential biomarker for several different diseases. For example, TMPRSS13 has been shown to be involved in the development and progression of cancer, and has been used as a biomarker for this disease in several studies. Additionally, TMPRSS13 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, and has been used as a biomarker for these conditions in several studies.

TMPRSS13 is a protein that is expressed in many different tissues throughout the body and has been shown to be involved in the regulation of electrical currents through the cell membrane. It is a potential drug target and has been identified as a biomarker for several different diseases. Further research is needed to fully understand the role of TMPRSS13 in these processes and to develop effective therapies for these diseases.

Protein Name: Transmembrane Serine Protease 13

The "TMPRSS13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMPRSS13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

TMPRSS15 | TMPRSS2 | TMPRSS3 | TMPRSS4 | TMPRSS5 | TMPRSS6 | TMPRSS7 | TMPRSS9 | TMSB10 | TMSB15A | TMSB15B | TMSB4X | TMSB4XP1 | TMSB4XP2 | TMSB4XP4 | TMSB4XP8 | TMSB4Y | TMTC1 | TMTC2 | TMTC3 | TMTC4 | TMUB1 | TMUB2 | TMX1 | TMX2 | TMX2-CTNND1 | TMX3 | TMX4 | TNC | TNF | TNF receptor-associated factor (TRAF) | TNFAIP1 | TNFAIP2 | TNFAIP3 | TNFAIP6 | TNFAIP8 | TNFAIP8L1 | TNFAIP8L2 | TNFAIP8L2-SCNM1 | TNFAIP8L3 | TNFRSF10A | TNFRSF10A-DT | TNFRSF10B | TNFRSF10C | TNFRSF10D | TNFRSF11A | TNFRSF11B | TNFRSF12A | TNFRSF13B | TNFRSF13C | TNFRSF14 | TNFRSF14-AS1 | TNFRSF17 | TNFRSF18 | TNFRSF19 | TNFRSF1A | TNFRSF1B | TNFRSF21 | TNFRSF25 | TNFRSF4 | TNFRSF6B | TNFRSF8 | TNFRSF9 | TNFSF10 | TNFSF11 | TNFSF12 | TNFSF12-TNFSF13 | TNFSF13 | TNFSF13B | TNFSF14 | TNFSF15 | TNFSF18 | TNFSF4 | TNFSF8 | TNFSF9 | TNIK | TNIP1 | TNIP2 | TNIP2P1 | TNIP3 | TNK1 | TNK2 | TNK2-AS1 | TNKS | TNKS1BP1 | TNKS2 | TNMD | TNN | TNNC1 | TNNI1 | TNNI2 | TNNI3 | TNNI3K | TNNT1 | TNNT2 | TNNT3 | TNP1 | TNP2 | TNPO1 | TNPO2